Peter J. Morley

Dihydropyrancarboxamides Related to Zanamivir:  A New Series of Inhibitors of Influenza Virus Sialidases. 1. Discovery, Synthesis, Biological Activity, and Structure−Activity Relationships of 4-Guanidino- and 4-Amino-4<i>H</i>-pyran-6-carboxamides

Paul W. Smith, Steven L. Sollis, Peter D. Howes et al. · Journal of Medicinal Chemistry · 1998 · 339 citations · Full text

Greater Inhibitory Activity, New Series, Antiviral Drug +16

The Interaction of Neuraminidase and Hemagglutinin Mutations in Influenza Virus in Resistance to 4-Guanidino-Neu5Ac2en

Tony Blick, Anjali Sahasrabudhe, Mandy McDonald et al. · Virology · 1998 · 108 citations

Viral Evolution, Medicine, Pathogenesis +7

Zanamivir Susceptibility Monitoring and Characterization of Influenza Virus Clinical Isolates Obtained during Phase II Clinical Efficacy Studies

Jacqueline M. Barnett, A. Cadman, D Gor et al. · Antimicrobial Agents and Chemotherapy · 2000 · 106 citations · Full text

Vaccination, Paired Isolates, Viral Diagnostics +11

Conserved Features in the Extracellular Domain of Human Toll-like Receptor 8 Are Essential for pH-dependent Signaling

Rebecca J. Gibbard, Peter J. Morley, Nicholas J. Gay · Journal of Biological Chemistry · 2006 · 83 citations · Full text

Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injury

Alastair Proudfoot, Andrew I. Bayliffe, Cecilia O’Kane et al. · Thorax · 2018 · 81 citations · Full text